{
  "pmcid": "12428795",
  "sha256": "a3a431851138f2e18cc7ce833ba0f587defdd5ac2c28e12e384adc644f9cb7a4",
  "timestamp_utc": "2025-11-09T23:37:37.599663+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.415897435897438,
    "reading_ease": 36.37076923076924,
    "word_count": 234
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Intravenous Preemptive Analgesia in Vitreoretinal Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "165 patients were randomly assigned"
      },
      "Participants": {
        "score": 2,
        "evidence": "patients undergoing vitreoretinal surgery (VRS) under general anesthesia (GA)"
      },
      "Intervention": {
        "score": 2,
        "evidence": "AoA-guided GA with IPA of 1 g paracetamol, 2.5 g metamizole, or both"
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial assessed the effect of intravenous preemptive analgesia (IPA)"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of PONV, OCR, and OER within 24 hours postoperatively"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation used sealed envelopes, and allocation was concealed"
      },
      "Blinding": {
        "score": 2,
        "evidence": "Blinding was applied to outcome assessors and patients"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "165 patients were randomly assigned... Data collection spanned January 2018 to December 2022"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Of the 153 patients analyzed... The analysis was per-protocol"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "PONV occurred in 4%, OCR in 10%, and OER in 0%... The effect size for PONV was not significant between groups"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were minimal and similar across groups"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT03389243"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified"
      }
    },
    "total_score": 20,
    "max_score": 25
  }
}